Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enliven Treateutics

20.51
+0.66003.32%
Post-market: 20.510.00000.00%17:43 EDT
Volume:221.18K
Turnover:4.53M
Market Cap:1.01B
PE:-10.84
High:20.79
Open:19.95
Low:19.65
Close:19.85
Loading ...
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 27, 2024

Correspondence

Form CORRESP - Correspondence
Apr 19, 2024

Correspondence

Form CORRESP - Correspondence
Apr 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2024

Major Issues Report

Form 8-K - Current report